Abstract
DNA double-strand breaks (DSBs) are the fatal type of DNA damage mostly induced by exposure genome to ionizing radiation or genotoxic chemicals. DSBs are mainly repaired by homologous recombination (HR) and nonhomologous end joining (NHEJ). To repair DSBs, a large amount of DNA repair factors was observed to be concentrated at the end of DSBs in a specific spatiotemporal manner to form a repair center. Recently, this repair center was characterized as a condensate derived from liquid-liquid phase separation (LLPS) of key DSBs repair factors. LLPS has been found to be the mechanism of membraneless organelles formation and plays key roles in a variety of biological processes. In this review, the recent advances and mechanisms of LLPS in the formation of DSBs repair-related condensates are summarized.
Similar content being viewed by others
Facts
-
Liquid-liquid phase separation (LLPS) has emerged as a key mechanism underlying the formation of liquid-like membraneless structures in cells.
-
DNA double-strand breaks (DSBs) are the biggest threat to genome integrity, which are typically repaired by HR and NHEJ.
-
In this review, we summarized the roles of LLPS in DSBs repair.
Open questions
-
What are the general features of LLPS, such as the characteristics, mechanisms, regulators, and functions?
-
Does LLPS participate in the process of DSBs repair?
-
What are the functions of LLPS in the compartmentalization of DSBs repair centers? How are these condensates induced by DNA damage?
Introduction
A cell can be thought of as a busy “factory”, running a variety of different tasks at the same time. To ensure the accuracy of independent tasks, a cell is compartmentalized into different departments for each specialized task. The main form of compartmentation is achieved by the membranes, which separate a cell into individual spaces by surrounding like walls. As well known, some big cellular organelles, including the nucleus, mitochondria, Golgi bodies, and endoplasmic reticulum, are compartmentalized with membranes [1]. However, there are many organelles, such as nucleolus, paraspeckle, and stress granules, which maintain stable structure and separated spaces without membranes [2], while the underlying mechanisms remain a mystery. Recently, this mystery driving force has been ascribed to the liquid-liquid phase separation (LLPS) of macromolecules.
The concept of LLPS was first raised by Dr. Anthony A. Hyman in 2009 [3]. They reported that P granules exhibited liquid-like properties, which was referred as liquid-liquid phase separation in their following studies. After ten years of study, LLPS has been reported to play key roles in not only the formation of canonical membraneless organelles, but also almost every locally performed biological process, including heterochromatin formation, transcription activation, RNA decay, signal transduction, and DNA repair [4,5,6,7,8].
Given the participation and activation of many nucleases, the task of DNA damage repair needs to be restricted in a compartmentalized space to ensure genome stability. As the most fatal type of DNA damage, DNA double-strand breaks (DSBs) are the main threat to genome integrity. DSBs are mainly repaired by homologous recombination (HR) and nonhomologous end joining pathway (NHEJ), involving dozens of repair factors [9,10,11,12]. The condensation of DNA damage response and repair factors at the DSBs ends has been observed over thirty years [13,14,15], which is considered as the result of their direct or indirect interaction with the factors already present at DSBs. However, there are still some phenomena that can’t be explained by this theory, e.g., the dynamic exchange of 53BP1 and RAD52 at DNA damage foci [16, 17]; the spatiotemporal changes of 53BP1 and BRCA1 foci [18,19,20]. Here, we provide a glance over recent advances in LLPS study, discuss the role of LLPS in DSBs repair factors condensation and its mechanism, and how specific LLPS are induced at DSBs. Overall, this review highlights the key functions of LLPS in the compartmentalization of DSBs repair center.
Brief review on liquid-liquid phase separation
Characteristics of liquid-liquid phase separation
Recently, LLPS has emerged as an underlying mechanism that regulates the formation of liquid-like membraneless structures in cells, which are also referred to as biomolecular condensates. Condensates produced by LLPS, including the nucleolus, paraspeckles, stress granules, P granules, Cajal bodies, and others, provide a compartmentalized space suitable for various biochemical reactions within a cell. When biomolecules undergo LLPS, they separate into a highly concentrated dense phase and a concomitant dilute phase, in which dynamic material exchange takes place over short timescales [2, 21].
Generally, LLPS has two distinct characteristics: dynamic diffusion and reversible compartmentalization. Based on this phenotype, fluorescence recovery after photobleaching (FRAP) is commonly considered a useful method to define a liquid-like biomolecular condensate in vivo. If the target protein labeled with a fluorescence tag exhibits spherical shapes and recovers from photobleaching, it is considered undergoing LLPS. Meanwhile, properties of droplet-like condensates such as fusion and fission help to distinguish liquid from solid or gel-like properties [22,23,24] (Fig. 1A).
Importantly, the occurrence of LLPS is highly dependent on the concentration and physicochemical identities of the biomolecules and the surrounding environment, such as temperature, pH, salt type, salt concentration, and the coexisting biological macromolecules. As usual, LLPS can only be triggered when the concentration of biomolecules reaches a threshold. Up to the threshold concentration, higher concentration of biomolecules, lower salt concentration in the physiological environment as well as suitable temperature and pH are more likely to promote phase separation [22, 25].
Mechanisms of LLPS
Biological macromolecules such as proteins and nucleic acids are prone to undergo LLPS under certain conditions, many of which are not common in living cells. In fact, only a small percentage of macromolecules are capable of phase separation in physiological contexts. In recent years, using the advantages of super-resolution microscopy and electron microscopy, the common characteristics of biomolecules that undergo LLPS in living cells have gradually become known [26, 27] (Fig. 1B).
LLPS of multivalent biomolecules
Biomolecules that can phase separate under physiological conditions are usually multivalent and prone to make intra- or inter-molecular interactions [28, 29]. The interactions often occur between proteins or between proteins and nucleic acids. Such molecules containing multivalent proteins or nucleic acids are commonly referred to as scaffolds, which are indispensable for condensate formation. The clients are recruited to the scaffolds, bound to them, and separated into condensates. Clients themselves cannot undergo LLPS and are recruited and regulated by scaffolds. In addition, condensate formation is related to the stoichiometry and valency of scaffolds and clients [22, 30, 31].
LLPS of proteins with modular domains
Proteins composed of modular interaction domains such as Nephrin, Nck, and neural Wiskott-Aldrich Syndrome protein (N-WASP) undergo phase separation via the interactions between the modular domains. Nephrin comprises three phosphotyrosines (pTyrs) motifs that can interact with the SH2 domains in Nck. Also, Nck contains SH3 domains that can bind the proline-rich motifs in N-WASP. This Nephrin-Nck-N-WASP complex in the actin-regulatory signaling pathway can form phase separation-induced clusters on lipid bilayers upon LLPS [28, 32]. Nucleolar protein Nucleophosmin 1 (NPM1) contains an oligomerizing domain and negatively charged region, which enable NPM1 to assemble into polymers and bind to positively charged Arg-rich motifs containing proteins. Besides, NPM1 also interacts with multivalent nucleic acids and then undergoes LLPS [29, 33]. The number of the interaction modular domains and the affinity between them are important factors that promote LLPS. Generally, more interaction modular domains and higher affinity help to form larger condensates and facilitate LLPS at lower protein concentrations [28, 34].
LLPS of proteins with intrinsically disordered regions
Proteins with intrinsically disordered regions (IDRs) are usually prone to undergo LLPS. IDRs are devoid of constant tertiary structure, therefore is hard to exhibit abundant conformational changes and three-dimensional structures. However, IDRs often contain repeated elements, another type of weak multivalent interaction that mediate LLPS. The IDRs consist of low-complexity sequences and are composed of unvaried amino acids such as serine, glutamine, glycine, tyrosine, phenylalanine, and asparagine. Lacking diversity of amino acid types, IDRs often contain Gly/Ser-Phe/Tyr-Ser/Gly sequences and poly-Gln and poly-Asn regions, which may provide multiple motifs for interacting with RNAs and drive LLPS through dipolar interactions in cells [30, 35,36,37,38]. Emerging evidence shows that aromatic residues may play an important role in promoting LLPS. For example, the IDR in DDX4 can facilitate LLPS via cation-pi interactions between the Phe-Gly repeats and Arg residues. The N-terminal disordered tails of Ddx4 form condensates both in vivo and in vitro. Besides, many disordered proteins associated with membraneless organelles have the similar sequence characteristics as Ddx4 [39, 40]. In contrast, LLPS may be destroyed when aromatic residues mutate, such as the mutation of Tyr residues in BuGZ, FUS, and Nephrin intracellular domain [41,42,43]. Besides, interactions between the blocks of oppositely charged residues in IDR-containing proteins also contribute to the promotion of LLPS. In addition to the interactions among amino acids, IDR-containing proteins can also undergo LLPS via interactions involving the polypeptide backbone. For instance, RNA-binding proteins including FUS, hnRNPA2, and CIRBP undergo LLPS via interactions between stretches of b-strands occurring a few at a time [44,45,46].
Regulators of LLPS
RNA
Increasing evidence suggests that RNAs play an essential regulatory role in triggering LLPS, such as mRNA, rRNA, and long non-coding RNA (lncRNA). RNAs usually serve as a bridge to connect multiple RNA-binding proteins (RBPs), which initiates LLPS by promoting the weak multivalent interaction between proteins or between RNAs and proteins [47, 48]. For example, lncRNA nuclear paraspeckle assembly transcript 1 (NEAT1) binds RBPs including non-POU domain containing octamer-binding protein (NONO) and splicing factor proline and glutamine (SFPQ), and promotes LLPS to form paraspeckles [49,50,51]. Damage-induced long non-coding RNAs (dilncRNAs) interact with 53BP1 and promote its LLPS at the DSBs sites [48]. Additionally, recent research suggests that multiple N6-methyladenosine (m6A) residues containing mRNAs may act as a multivalent scaffold to bind the YTHDF proteins, thereby driving its LLPS [52].
Posttranslational modifications
Posttranslational modifications (PTMs) are important regulators of protein function and stability, including phosphorylation, arginine methylation, acetylation, glycosylation, Poly(ADP-ribosyl)ation (PARylation), ubiquitylation and SUMOylation [53]. PTMs regulate phase separation by altering the multivalent interactions between macromolecules, recruiting other biomolecules into the condensate, or excluding other biomolecules from the condensate [54]. Research data indicate that protein arginine methylation at specific Arg residues results in the inhibition of condensate formation by diminishing multivalent cation-π interactions between Arg and aromatic residues. For example, arginine methyltransferase inhibitor enhances LLPS of FUS [55, 56]. In contrast to methylation, acetylation and phosphorylation can either promote or inhibit LLPS by affecting the protein conformation and protein-protein or/and protein-nucleic acid interactions. Phosphorylation of FUS inhibits its LLPS, while phosphorylation at Ser residues promotes TDP-43 LLPS [57,58,59,60]. In addition, PARylation is another PTM that is known to regulate the assembly and disassembly of RNA-binding proteins. Several lines of evidence reveal the important role of PARylation in regulating the LLPS of ribonucleoprotein (RNP) granules, such as TDP-43 and hnRNPA1 [61, 62].
ATP
Studies have shown that ATP affects the formation of LLPS by acting as an energy source or a hydrotrope that effectively changes the solubility of proteins. Many IDR-containing proteins that undergo LLPS exhibit FRAP, whereas depletion of ATP makes it difficult to recover from photobleaching. In line with this finding, several evidences reveal that the formation of nuclear condensate is significantly promoted in the presence of ATP. In contrast, a high concentration of ATP can also prevent LLPS of some proteins, e.g., Kang et al. reported that a high concentration of ATP may lead to the disassembly of FUS condensate [63,64,65].
Functions of LLPS
As described above, biomolecular condensates are very common in cells, such as nucleolus, paraspeckles, and stress granules. These condensates provide independent spaces for a lot of biochemical reactions including enzymatic reactions, which are essential to cell survival. Accumulated studies have shown that LLPS plays important roles in regulating various cellular processes, such as DNA damage repair, gene expression, autophagy, chromatin organization, and biochemical pathway organization [21, 66, 67]. For example, Gibson et al. revealed that LLPS participated in establishing and maintaining chromatin compartments. The authors found that the reconstituted chromatin was able to form a dynamic liquid phase in the presence of physiologic salts, depending on the interactions between DNA and the histone H4. The linker DNA length, histone H1, and acetylation are the regulatory factors of chromatin LLPS. Their study suggested that LLPS plays an essential role in regulating the spatial organization of the genome [68].
Mounting studies have revealed that aberrant phase separation contributes to various human diseases such as tumorigenesis, neurodegenerative disorders, and some rare diseases. For instance, it has been reported that LLPS participates in neural development. The communications between the synapses are dependent on the molecular condensates via LLPS. Thus, LLPS plays a crucial role in signaling transmission in neuron [69]. Besides, microtubule-associated protein Tau can undergo LLPS. Pathologically, the sialylation of the Tau protein makes its condensation transit from liquid-like to solid-like that can’t be degraded, which further results in various neurodegenerative diseases such as Alzheimer’s disease [70]. Besides, LLPS is also involved in the cell tumorigenesis process and may be associated with cancers. Take the tumor suppressor speckle-type BTB/POZ protein (SPOP) for example, SPOP can form liquid-like droplets via interaction with its substrates, which can inhibit cancer-associated protein aggregation. In some tumors, SPOP often has oncogenic mutations that disrupt its ability to undergo LLPS, contributing to tumor progression [71]. Moreover, aberrant LLPS was also reported to be the driving force of rare diseases. Zhu et al. found that abnormal LLPS is related to Noonan syndrome, a rare disease induced by SHP2 mutations. Their research suggested that diseased-associated SHP2 mutants form puncta in cells via aberrant LLPS, accounting for MAPK hyperactivation [72].
LLPS in DSBs repair
A glance on DSBs repair mechanism
DSBs are the biggest threat to genome integrity. DSBs are mainly resulted from ionizing radiation (e.g., tumor radiotherapy), genotoxic chemicals (e.g., tumor chemotherapy), stalled replication forks, and reactive oxygen species (ROS). DSBs are repaired by either homologous recombination (HR) or nonhomologous end joining (NHEJ). HR is conducted in an error-free manner, that needs sister-chromatid or homologous chromosomes as a template and mainly functions in the S/G2 phase of cell cycle. In contrast, NHEJ ligates the DNA breaks directly in an error-prone way and works throughout the cell cycle. When DSBs occur, the MRE11/RAD50/NBS1 (MRN) complex binds to DSBs rapidly and functions as a DSBs sensor, which further recruits the protein kinase ataxia-telangiectasia mutated (ATM) and triggers ATM activation. ATM-mediated H2A.X phosphorylation at S139 serves as a platform for scaffold protein MDC1 that promotes the recruitment and retention of other DSBs repair factors, such as the MRN complex, RNF8, BRCA1, and 53BP1. For HR repair, the MRN complex catalyzes the generation of 3′ ssDNA that is further bound and protected by the RPA complex; consequently, the recombinase RAD51 replaces the RPA complex and forms RAD51/ssDNA filament, which is responsible for the search for homologous sequence and the invasion to dsDNA. For NHEJ repair, ku70/80 heterodimer binds to DSBs and recruits and activates protein kinase DNA-PK; further, the XRCC4/DNA LIG4/XLF complex is further recruited to complete the ligation of DSBs ends [12, 73,74,75].
DSBs repair factors undergoing LLPS
53BP1
53BP1 was originally identified as a p53 tumor suppressor binding protein [76, 77], although an increasing number of studies have focused on its roles in genomic integrity and DNA damage repair. 53BP1 is a large protein containing 1972 amino acids and several functional domains, including 28 Ser/Thr-Gln (S/T-Q) sites at its N-terminal, an oligomerization domain (OD), a Gly- and Arg-rich (GAR) motif, a tandem Tudor motif responsible for binding to dimethylated Lys20 of histone 4 (H4K20me2), a ubiquitylation-dependent recruitment (UDR) motif responsible for the interaction with ubiquitylated H2AK15 (H2AK15ub), and a BRCA1 carboxy-terminal (BRCT) repeats responsible for its interaction with DNA repair factors [78,79,80]. 53BP1 is a regulator of DSBs repair pathway choice, that promotes NHEJ and prevents HR [81, 82]. 53BP1 is reported to interact with key factors in different stages of DSB response, including DSBs sensor (MRN complex) [83], DSBs repair factors (BRCA1, RIF1) [84], DNA damage response transducers (ATM, ATR, CHK1/2) [83, 85,86,87], and cell cycle arrest-related factors (p53) [88, 89]. Various studies have shown that 53BP1 abnormal expression was correlated with carcinogenesis, thus targeting 53BP1 may be a promising strategy for treating cancer [90].
53BP1 is the first characterized phase-separated DSBs repair protein. Based on the CRISPR/Cas9-mediated endogenous 53BP1 tagging cells, Kilic et al. described the dynamic property and droplet-like behavior of 53BP1 condensates, presenting as frequent fusion and fission event. Also, the authors identified that the 53BP1 repair compartment at DNA lesions and DSBs sites exhibited the characteristics of liquid-liquid phase separation. As described above, the formation of 53BP1 condensates is influenced by physiological conditions, such as temperature, salt concentration, and osmotic pressure, while the upstream accumulation of γH2AX and MDC1 is not. Using optoDroplet, a tool of light-controlled LLPS, to perform gain-of-function experiments, the authors found that tumor repressor protein p53 was enriched in 53BP1 condensates. The BRCT domain of 53BP1 might participate in the assembly of p53 into optoDroplets. Moreover, the phase-separated 53BP1 compartments may contribute to the stabilization of p53 upon DNA damage. Disruption of 53BP1 condensates diminished the activation of p53-target genes, such as p21. Once the phase separation of 53BP1 was impaired, both DNA damage-induced p53 stabilization and p21 expression were decreased substantially [66]. Later, Pessina et al. also reported the LLPS property of 53BP1 condensates. In this study, they characterized damage-induced long non-coding RNAs (dilncRNA), a class of non-coding RNA synthesized at DSBs by a complete RNA polymerase II preinitiation complex, MED1, and CDK9, were required for the formation of DDR foci and 53BP1 condensates. The absence of dilncRNA is essential for stimulating LLPS of DDR factors (including 53BP1) in the shape of foci [48]. This study provides the mechanism of irradiation-induced 53BP1 phase separation at DSBs site. Further, scaffold protein AHNAK was identified as the inhibitor of 53BP1 phase separation [91]. AHNAK is a G1-phase-enriched interactor of 53BP1, that binds to the oligomerization domain of 53BP1 and diminishes its multimerization potential. Loss of AHNAK results in hyper-accumulation of 53BP1 on chromatin and enhanced phase separation, culminating in an elevated p53 response (Fig. 2A). Consistent with this report, Zhang et al. demonstrated that in normal cultured cells, 53BP1 condensates bound to heterochromatin and contributed to the maintenance of heterochromatin integrity and genome stability [92].
Poly(ADP-ribose)
PARylation was first described more than 50 years ago. It is known as a DNA-dependent reaction that consumes nicotinamide adenine dinucleotide (NAD+) to build poly(ADP-ribose) (PAR) chains [93, 94]. The major enzyme catalyzing this reaction is PAR polymerase 1 (PARP1) [95], which regulates a number of biological processes including DNA repair [96, 97], carcinogenesis [98, 99], metabolism [100, 101] signaling [102, 103], gene transcription [104, 105] and cell death [105, 106]. In response to DNA damage, PARP1 quickly detects and binds to both single-strand breaks (SSBs) and DSBs and starts rapid PAR synthesis, which then recruits PAR-binding DDR factors for DNA damage repair [107, 108]. Additionally, there is accumulating evidence suggesting that many RNA-binding proteins (RBPs) are recruited to the sites of DSBs through interacting with PAR, leading to the recruitment of DSBs repair proteins [109,110,111].
It was recently proposed that functional interactions between PAR and RBPs are assembled through LLPS [109, 111, 112]. At the damaged DNA site, PAR serves as a scaffolding factor for the assembly of these RBPs that contain IDR, thereby initiating dynamic intracellular compartments for the spatial segregation of damaged DNA [113, 114]. This process relies on electrostatic interactions between positively charged arginine–glycine–glycine (RGG) repeats and negatively charged PAR, which is amplified by prone prion-like domains [112]. The assembly of RBPs at DNA break sites is dynamic and reversible mainly due to PAR glycohydrolase (PARG) activity [109]. PARG is sufficient to dissociate damaged DNA-rich compartments in vitro and initiates the nucleocytoplasmic shuttling of FUS in cells, providing a potential link between DNA repair and neurodegenerative diseases [109]. Therefore, local PAR formation can orchestrate intracellular phase transitions, allowing for their controlled formation, timely dissolution, and finally facilitating DNA repair.
RNA-binding proteins
FUS
Fused in sarcoma (FUS) is an RNA-binding protein [115] that is involved in unique functions in gene transcription, RNA shearing, RNA transport, and translation [116]. In addition, FUS was also found to maintain genomic stability in response to DNA damage [117]. In particular, FUS is an early DDR factor, being recruited to the DSBs site dependent on PARP activity [118,119,120]. After being recruited, FUS directly interacts with DNA repair factors to facilitate DNA repair [121, 122]. Recent studies show that FUS undergoes LLPS, which is associated with the pathogenesis of the neurodegenerative disease [41, 56, 123]. An optogenetic tool, named as “optoDroplet”, has been used to study condensed phases driven by the IDRs of FUS. Lately, it was proposed that LLPS of FUS is necessary for the initiation of the DDR [124]. FUS is required for the recruitment of the DDR factors to DNA damage sites, including KU80, NBS1, 53BP1, SFPQ, and other RBP implicated in the DDR [125]. LLPS allows FUS to locally form droplet-like compartments, which further recruit these DDR factors and promote DSBs repair [126]. Moreover, the recruitment of FUS at the DSBs site is mediated by its interaction with PAR, which further promotes the assembly of damaged DNA-rich compartments (Fig. 2B) [109, 127].
NONO
The non-POU domain containing octamer-binding (NONO), an RNA and DNA binding protein, belongs to the Drosophila behavior human splicing (DBHS) family [128, 129]. NONO engages in various biological processes, including but not limited to DNA repair [130, 131], RNA splicing [132], RNA silencing [133], transcriptional regulation [128], and nuclear mRNA retention [134]. NONO is involved in DNA damage repair mainly through promoting the NHEJ pathway [135, 136]. NONO is also a PAR-binding protein and its recruitment to DNA damage sites is dependent on PARP activation [110]. Recently, NONO was found to bind to NEAT1 to form paraspeckle, a membraneless nuclear body driven by LLPS [49]. Our recent study reported that NONO condensates recruit nuclear EGFR and DNA-PK to enhance their interaction. Disruption of NONO droplets with LLPS inhibitor significantly reduced the DNA damage-induced EGFR/NONO as well as EGFR/DNA-PK complex, and suppressed the phosphorylation of DNA-PK at T2609 (Fig. 2F) [137].
DDX3X
DDX3X, a member of the DEAD-box RNA helicase family, plays a ubiquitous role in RNA metabolism [138, 139]. DDX3X also plays an important role in protecting genome integrity and its dysregulation is implicated in the development of cancer [140, 141]. Several studies have demonstrated that DDX3X is important for DNA repair [111, 142, 143]. Consistent with the observation of RNA-binding proteins recruited to DNA damage sites [144], DDX3X is recruited to the DSBs site in a PARP1-dependent manner. This recruitment is mediated by PAR-triggered LLPS of DDX3X. Inhibition of LLPS and CRISPR/Cas9-mediated knockout of PARP1 reduced DDX3X recruitment, suggesting a novel mechanism by which DDX3X regulates DSBs repair (Fig. 2D) [111].
Other factors
Pre-rRNA
ncRNAs are essential regulators of DSBs repair factors condensation [145]. In addition to dilncRNAs that stimulate DSBs-induced 53BP1 condensation [48], pre-ribosomal RNA (pre-rRNA) also regulates the LLPS of DNA repair factors. Gan et al. find that pre-rRNA and ribosomal proteins, RNase MRP, and snoRNAs are localized in XY body and DSBs foci, and transient inhibition of RNA polymerase I abolishes foci formation of DSBs repair factor as well as DSBs repair. Mechanically, the FHA domain and PST repeats of MDC1 recognize pre-rRNA and mediate the formation of a phase-separated DSBs repair center (Fig. 2C) [146].
MRNIP
MRN-interacting protein (MRNIP) was first identified as a regulator of genome stability using an RNAi-based screen by Collis and colleagues [147]. It binds to the MRN complex and promotes MRN-mediated ATM activation and DNA end resection. Meanwhile, MRNIP was found to be a protector of replication fork [148]. Our recently published study reported that MRNIP formed liquid-like condensates in the nucleus, which recruited and concentrated the MRN complex [149]. When DSBs occur, MRNIP condensates move to the DSBs site and incorporate damaged DNA, enhancing the MRN complex-mediated ATM activation and DSBs end resection (Fig. 2G). The acceleration of MRNIP is correlated with the radioresistance of colorectal cancer. Consistent with our findings, Kazi et al. report that MRNIP has an essential function in spermatogenesis during meiosis I by forming drop-like accumulations interacting with the sex body [150].
Rad52
Yeast Rad52 protein is the functional analog of human BRCA2. After the generation of RPA-coupled ssDNA, Rad52 stimulates the removal of RPA and recruitment of Rad51 recombinase to ssDNA [151]. Rad51-coated ssDNA further searches and invades the homologous region of template DNA [152]. Oshidari et al. first show that in yeast, Rad52 protein undergoes LLPS at DSBs site. Rad52 proteins at different DNA damage sites assemble into liquid droplets and fuse into a repair center droplet via the action of petite DNA damage-induced intranuclear microtubule filaments (pti-DIMs). The resulting droplets tether the repair center to longer DIM-mediated mobilization of damaged DNA for repair [153]. Miné-Hattab et al. investigated the physical nature of Rad52 condensate using Single Particle Tracking (SPT) and Photo Activable Localization Microscopy (PALM) in Saccharomyces cerevisiae cells. They found that Rad52 molecules within condensate moved faster than the whole focus itself and the damaged DNA, indicating that most of Rad52 molecules within the DNA repair center were not bound to damaged DNA [154]. Their data further supports the phase-separated droplet properties of Rad52 at the DSBs site (Fig. 2E).
MtSUVR2
Medicago truncatula SUVR2 (MtSUVR2) is a plant-specific histone methyltransferase that catalyzes the conversion of histone H3 lysine 9 monomethylation (H3K9me1) to H3K9me2/3. The SET domain of AtSUVR2 in Arabidopsis has been shown to interact with histone H3, and AtSUVR4 also interacts with histone H3 [155, 156]. To investigate whether MtSUVR2 participates in DSBs repair, Liu et al. first confirmed that MtSUVR2-mediated H3K9me2 and heterochromatin formation affected DSBs repair. Further, they found that the DSBs-induced MtSUVR2 forming phase-separated condensate at the DNA damage site. The IDR1 and low-complexity domain of MtSUVR2 determined its LLPS, whereas its IDR2 domain determined the interaction with MtRAD51. Interestingly, MtSUVR2 condensates drive the LLPS of MtRAD51, which enhances the stability of MtRAD51 and facilitates HR-mediated DSBs repair (Fig. 2H) [157].
Concluding remarks
Accurate and efficient DSBs repair is crucial for cell survival and genome integrity. For efficient repair, a large amount of repair factors is recruited and highly concentrated on DSBs end. However, the nucleases activated and required by DSBs repair are big threats to genome DNA, for which the DSBs repair process needs to be restricted in a compartmentalized space. The formation of phase-separated repair cores driven by LLPS supported this requirement. Up to now, LLPS has been shown to play important roles in different stages of DSBs repair, including DSBs sensing, repair initiation, and pathway choice.
The spatiotemporal regulation of repair factors recruitment and dissolving at DSBs end is required for DSBs repair. Our and other groups’ studies have found that many DSBs repair proteins undergo LLPS, which may form condensates at DSBs end and then recruit the downstream repair factors to the damaged site. However, do these LLPS factors interplay with each other? Is the physical-chemical interaction between different condensates required for the accurate spatiotemporal sequence of DSBs repair factors? For instance, Kakarougkas et al. showed that at the late stage of HR, 53BP1 condensates would be pushed out of the repair core by BRCA1 puncta, presenting as a phenomenon that 53BP1 condensates surrounding BRCA1 foci like a shell, but not just dissolved from DSBs [19]. Is this process an interplay between 53BP1 condensates and BRCA1 condensates? Additionally, Chiolo et al. reported that in the DSBs repair process of heterochromatic repetitive DNAs, heterochromatin undergoes dramatic expansion and dynamic protrusions to relocalize the HR repair center out of heterochromatin to associate with RAD51, thereby suppressing the excessive recombination of repeat sequences [158]. In the case that HP1α-mediated heterochromatin has been shown as a condensate driven by LLPS, is the relocalization an interplay between condensates of repair core and heterochromatin?
The survival benefit of PARP1 inhibitor in BRCA1-deficient breast cancer proved that the DNA repair pathway is a promising target for cancer treatment. Meanwhile, LLPS has been found to play pivotal roles in tumorigenesis [159, 160], and inhibition of global LLPS by 1,6-hexanediol treatment showed remarkable inhibition of tumor growth and induction of tumor cell death [161], indicating that LLPS may be a promising target for cancer treatment. While 1,6-hexanediol, a general LLPS inhibitor, is highly toxic to normal cells, the development of LLPS inhibitors with low toxicity and higher specificity is needed. However, IDRs, the key driving force of LLPS, lack a stable 3-dimensional structure. Although there are many web tools to analyze the disordered region of LLPS proteins, it is still a big challenge to develop drugs targeting LLPS. Recently, several small molecule inhibitors targeting IDRs have been reported [162, 163]. For instance, EPI analogs have been proven as androgen receptor (AR) IDR-specific binding inhibitors. The specificity and efficiency were verified by in vitro system, cellular experiments, and mouse model [164, 165]. Meanwhile, EPI-002, as a first-in-class drug that directly binds to an IDR, is the first IDR-targeted small compound being tested in the clinic (Clinical trial information: NCT02606123) [163].
Over the last ten years, studies on LLPS have risen as a hot field, accompanied by the emergence of new technologies for analyzing condensate properties, functions, and mechanisms. For condensate structure examination, we can use solution and solid-state nuclear magnetic resonance spectroscopy (NMR, ssNMR), small-angle x-ray scattering (SAXS), cryo-electron microscopy (cryo-EM), and atomic force microscopy (AFM), as well as single-molecule fluorescence microscopy (SMFM) techniques including fluorescence fluctuation spectroscopy (FFS) and single-molecule fluorescence resonance energy transfer (smFRET) [166]. For instance, using single-molecule microscopy in living cells, Miné-Hattab et al. characterized the different physical features of repair foci; most Rfa1 molecules are bound to the ssDNA while Rad52 molecules are free to explore the entire focus, reflecting the existence of a liquid Rad52 droplet around damaged DNA [154]. This method may be used to distinguish liquid-like droplets from foci. To identify the key domains of LLPS, many websites, e.g., PONDR, PLAAC, and PSPredictor, provide tools to predict the IDRs and the LLPS potency of target proteins [21, 22, 167]. In particular, OptoIDR provides a LLPS inducible tool to investigate LLPS function by gain-of-function [168]. However, there are still several unsolved points urging for new techniques. Firstly, loss-of-function experiments are mostly performed by deleting IDRs responsible for LLPS. However, as IDRs are usually relatively long polypeptides (from tens to hundreds of amino acids), removing them may disrupt protein structures and essential functional domains. Besides, we need a method to identify all LLPS proteins and evaluate their LLPS potency in cells, thereby stress-induced LLPS changes could be screened genome-wide.
Although LLPS has shed light on the mechanism underlying many biophysical features of condensates, some deep questions need to be further disclosed in future research. Firstly, the basic physical and chemical theory of LLPS remains largely unknown, which would be a key to developing the method of targeting LLPS in disease treatment. Additionally, in the bioengineering field, could the materials with inducible LLPS properties be used in biological research or clinical therapy? For example, vehicles incorporate drugs under the LLPS status while releasing the drugs under an inducible non-LLPS status in the tumor lesion to achieve a specific delivery of drugs.
References
Yang J, Griffin A, Qiang Z, Ren J. Organelle-targeted therapies: a comprehensive review on system design for enabling precision oncology. Signal Transduct Target Ther. 2022;7:379.
Gao Y, Li X, Li P, Lin Y. A brief guideline for studies of phase-separated biomolecular condensates. Nat Chem Biol. 2022;18:1307–18.
Brangwynne CP, Eckmann CR, Courson DS, Rybarska A, Hoege C, Gharakhani J, et al. Germline P granules are liquid droplets that localize by controlled dissolution/condensation. Science. 2009;324:1729–32.
Mehta S, Zhang J. Liquid-liquid phase separation drives cellular function and dysfunction in cancer. Nat Rev Cancer. 2022;22:239–52.
Xiao Q, McAtee CK, Su X. Phase separation in immune signalling. Nat Rev Immunol. 2022;22:188–99.
Boija A, Klein IA, Young RA. Biomolecular condensates and cancer. Cancer Cell. 2021;39:174–92.
Li H, Ernst C, Kolonko-Adamska M, Greb-Markiewicz B, Man J, Parissi V, et al. Phase separation in viral infections. Trends Microbiol. 2022;30:1217–31.
Su Q, Mehta S, Zhang J. Liquid-liquid phase separation: orchestrating cell signaling through time and space. Mol Cell. 2021;81:4137–46.
Stinson BM, Loparo JJ. Repair of DNA double-strand breaks by the nonhomologous end joining pathway. Annu Rev Biochem. 2021;90:137–64.
Zhao B, Rothenberg E, Ramsden DA, Lieber MR. The molecular basis and disease relevance of non-homologous DNA end joining. Nat Rev Mol Cell Biol. 2020;21:765–81.
Waterman DP, Haber JE, Smolka MB. Checkpoint responses to DNA double-strand breaks. Annu Rev Biochem. 2020;89:103–33.
Scully R, Panday A, Elango R, Willis NA. DNA double-strand break repair-pathway choice in somatic mammalian cells. Nat Rev Mol Cell Biol. 2019;20:698–714.
Register JR, Griffith J. RecA protein filaments can juxtapose DNA ends: an activity that may reflect a function in DNA repair. Proc Natl Acad Sci USA. 1986;83:624–8.
Cress AE, Kurath KM, Hendrix MJ, Bowden GT. Nuclear protein organization and the repair of radiation damage. Carcinogenesis. 1989;10:939–43.
Haaf T, Golub EI, Reddy G, Radding CM, Ward DC. Nuclear foci of mammalian Rad51 recombination protein in somatic cells after DNA damage and its localization in synaptonemal complexes. Proc Natl Acad Sci USA. 1995;92:2298–302.
Essers J, Houtsmuller AB, van Veelen L, Paulusma C, Nigg AL, Pastink A, et al. Nuclear dynamics of RAD52 group homologous recombination proteins in response to DNA damage. EMBO J. 2002;21:2030–7.
Bekker-Jensen S, Lukas C, Melander F, Bartek J, Lukas J. Dynamic assembly and sustained retention of 53BP1 at the sites of DNA damage are controlled by Mdc1/NFBD1. J Cell Biol 2005;170:201–11.
Chapman JR, Sossick AJ, Boulton SJ, Jackson SP. BRCA1-associated exclusion of 53BP1 from DNA damage sites underlies temporal control of DNA repair. J Cell Sci. 2012;125:3529–34.
Kakarougkas A, Ismail A, Katsuki Y, Freire R, Shibata A, Jeggo PA. Co-operation of BRCA1 and POH1 relieves the barriers posed by 53BP1 and RAP80 to resection. Nucleic Acids Res. 2013;41:10298–311.
Yasuhara T, Kato R, Hagiwara Y, Shiotani B, Yamauchi M, Nakada S, et al. Human Rad52 promotes XPG-mediated R-loop processing to initiate transcription-associated homologous recombination repair. Cell. 2018;175:558–70.
Sabari BR, Dall’Agnes A, Boija A, Klein IA, Coffey EL, Shrinivas K, et al. Coactivator condensation at super-enhancers links phase separation and gene control. Science. 2018;361:eaar3958.
Alberti S, Gladfelter A, Mittag T. Considerations and challenges in studying liquid-liquid phase separation and biomolecular condensates. Cell. 2019;176:419–34.
Shin Y, Brangwynne CP. Liquid phase condensation in cell physiology and disease. Science. 2017;357:eaaf4382.
Muiznieks LD, Sharpe S, Pomes R, Keeley FW. Role of liquid-liquid phase separation in assembly of elastin and other extracellular matrix proteins. J Mol Biol. 2018;430:4741–53.
Ruff KM, Roberts S, Chilkoti A, Pappu RV. Advances in understanding stimulus-responsive phase behavior of intrinsically disordered protein polymers. J Mol Biol. 2018;430:4619–35.
Maharana S, Wang J, Papadopoulos DK, Richter D, Pozniakovsky A, Poser I, et al. RNA buffers the phase separation behavior of prion-like RNA binding proteins. Science. 2018;360:918–21.
Jain S, Wheeler JR, Walters RW, Agrawal A, Barsic A, Parker R. ATPase-modulated stress granules contain a diverse proteome and substructure. Cell. 2016;164:487–98.
Li P, Banjade S, Cheng HC, Kim S, Chen B, Guo L, et al. Phase transitions in the assembly of multivalent signalling proteins. Nature. 2012;483:336–40.
Mitrea DM, Cika JA, Guy CS, Ban D, Banerjee PR, Stanley CB, et al. Nucleophosmin integrates within the nucleolus via multi-modal interactions with proteins displaying R-rich linear motifs and rRNA. Elife. 2016;5:e13571.
Banani SF, Lee HO, Hyman AA, Rosen MK. Biomolecular condensates: organizers of cellular biochemistry. Nat Rev Mol Cell Biol. 2017;18:285–98.
Banani SF, Rice AM, Peeples WB, Lin Y, Jain S, Parker R, et al. Compositional control of phase-separated cellular bodies. Cell. 2016;166:651–63.
Banjade S, Rosen MK. Phase transitions of multivalent proteins can promote clustering of membrane receptors. Elife. 2014;3:e04123.
Mitrea DM, Grace CR, Buljan M, Yun MK, Pytel NJ, Satumba J, et al. Structural polymorphism in the N-terminal oligomerization domain of NPM1. Proc Natl Acad Sci USA. 2014;111:4466–71.
Wang J, Choi JM, Holehouse AS, Lee HO, Zhang X, Jahnel M, et al. A molecular grammar governing the driving forces for phase separation of prion-like RNA binding proteins. Cell. 2018;174:688–99.
Das RK, Ruff KM, Pappu RV. Relating sequence encoded information to form and function of intrinsically disordered proteins. Curr Opin Struc Biol. 2015;32:102–12.
Jensen MR, Ruigrok RW, Blackledge M. Describing intrinsically disordered proteins at atomic resolution by NMR. Curr Opin Struct Biol. 2013;23:426–35.
Lin Y, Currie SL, Rosen MK. Intrinsically disordered sequences enable modulation of protein phase separation through distributed tyrosine motifs. J Biol Chem. 2017;292:19110–20.
Borcherds W, Bremer A, Borgia MB, Mittag T. How do intrinsically disordered protein regions encode a driving force for liquid-liquid phase separation? Curr Opin Struct Biol. 2021;67:41–50.
Nott TJ, Petsalaki E, Farber P, Jervis D, Fussner E, Plochowietz A, et al. Phase transition of a disordered nuage protein generates environmentally responsive membraneless organelles. Mol Cell. 2015;57:936–47.
Lin YH, Forman-Kay JD, Chan HS. Sequence-specific polyampholyte phase separation in membraneless organelles. Phys Rev Lett. 2016;117:178101.
Burke KA, Janke AM, Rhine CL, Fawzi NL. Residue-by-residue view of in vitro FUS granules that bind the C-terminal domain of RNA polymerase II. Mol Cell. 2015;60:231–41.
Jiang H, Wang S, Huang Y, He X, Cui H, Zhu X, et al. Phase transition of spindle-associated protein regulate spindle apparatus assembly. Cell. 2015;163:108–22.
Pak CW, Kosno M, Holehouse AS, Padrick SB, Mittal A, Ali R, et al. Sequence determinants of intracellular phase separation by complex coacervation of a disordered protein. Mol Cell. 2016;63:72–85.
Han TW, Kato M, Xie S, Wu LC, Mirzaei H, Pei J, et al. Cell-free formation of RNA granules: bound RNAs identify features and components of cellular assemblies. Cell. 2012;149:768–79.
Kato M, Han TW, Xie S, Shi K, Du X, Wu LC, et al. Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels. Cell. 2012;149:753–67.
Kwon I, Kato M, Xiang S, Wu L, Theodoropoulos P, Mirzaei H, et al. Phosphorylation-regulated binding of RNA polymerase II to fibrous polymers of low-complexity domains. Cell. 2013;155:1049–60.
Lin Y, Protter DS, Rosen MK, Parker R. Formation and maturation of phase-separated liquid droplets by RNA-binding proteins. Mol Cell. 2015;60:208–19.
Pessina F, Giavazzi F, Yin Y, Gioia U, Vitelli V, Galbiati A, et al. Functional transcription promoters at DNA double-strand breaks mediate RNA-driven phase separation of damage-response factors. Nat Cell Biol. 2019;21:1286–99.
Hirose T, Yamazaki T, Nakagawa S. Molecular anatomy of the architectural NEAT1 noncoding RNA: the domains, interactors, and biogenesis pathway required to build phase-separated nuclear paraspeckles. Wiley Interdiscip RNA. 2019;10:e1545.
Fox AH, Nakagawa S, Hirose T, Bond CS. Paraspeckles: where long noncoding RNA meets phase separation. Trends Biochem Sci. 2018;43:124–35.
Yamazaki T, Souquere S, Chujo T, Kobelke S, Chong YS, Fox AH, et al. Functional domains of NEAT1 architectural lncRNA induce paraspeckle assembly through phase separation. Mol Cell. 2018;70:1038–53.
Ries RJ, Zaccara S, Klein P, Olarerin-George A, Namkoong S, Pickering BF, et al. m6A enhances the phase separation potential of mRNA. Nature. 2019;571:424–8.
Chen L, Liu S, Tao Y. Regulating tumor suppressor genes: post-translational modifications. Signal Transduct Target Ther. 2020;5:90.
Bah A, Forman-Kay JD. Modulation of intrinsically disordered protein function by post-translational modifications. J Biol Chem. 2016;291:6696–705.
Yang Y, Bedford MT. Protein arginine methyltransferases and cancer. Nat Rev Cancer. 2013;13:37–50.
Hofweber M, Hutten S, Bourgeois B, Spreitzer E, Niedner-Boblenz A, Schifferer M, et al. Phase separation of FUS is suppressed by its nuclear import receptor and arginine methylation. Cell. 2018;173:706–19.
Bentmann E, Neumann M, Tahirovic S, Rodde R, Dormann D, Haass C. Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43). J Biol Chem. 2012;287:23079–94.
Portz B, Lee BL, Shorter J. FUS and TDP-43 phases in health and disease. Trends Biochem Sci. 2021;46:550–63.
Carey JL, Guo L. Liquid-liquid phase separation of TDP-43 and FUS in physiology and pathology of neurodegenerative diseases. Front Mol Biosci. 2022;9:826719.
Ding X, Sun F, Chen J, Chen L, Tobin-Miyaji Y, Xue S, et al. Amyloid-forming segment induces aggregation of FUS-LC domain from phase separation modulated by site-specific phosphorylation. J Mol Biol. 2020;432:467–83.
Fu H, Liu R, Jia Z, Li R, Zhu F, Zhu W, et al. Poly(ADP-ribosylation) of P-TEFb by PARP1 disrupts phase separation to inhibit global transcription after DNA damage. Nat Cell Biol. 2022;24:513–25.
Liu C, Fang Y. New &insights of poly(ADP-ribosylation) in neurodegenerative diseases: a focus on protein phase separation and pathologic aggregation. Biochem Pharmacol. 2019;167:58–63.
Patel A, Malinovska L, Saha S, Wang J, Alberti S, Krishnan Y, et al. ATP as a biological hydrotrope. Science. 2017;356:753–6.
Song J. Adenosine triphosphate energy-independently controls protein homeostasis with unique structure and diverse mechanisms. Protein Sci. 2021;30:1277–93.
Kang J, Lim L, Song J. ATP enhances at low concentrations but dissolves at high concentrations liquid-liquid phase separation (LLPS) of ALS/FTD-causing FUS. Biochem Biophys Res Commun. 2018;504:545–51.
Kilic S, Lezaja A, Gatti M, Bianco E, Michelena J, Imhof R, et al. Phase separation of 53BP1 determines liquid-like behavior of DNA repair compartments. EMBO J. 2019;38:e101379.
Fujioka Y, Alam JM, Noshiro D, Mouri K, Ando T, Okada Y, et al. Phase separation organizes the site of autophagosome formation. Nature. 2020;578:301–5.
Gibson BA, Doolittle LK, Schneider M, Jensen LE, Gamarra N, Henry L, et al. Organization of chromatin by intrinsic and regulated phase separation. Cell. 2019;179:470–84.
Wu X, Cai Q, Feng Z, Zhang M. Liquid-liquid phase separation in neuronal development and synaptic signaling. Dev Cell. 2020;55:18–29.
Kanaan NM, Hamel C, Grabinski T, Combs B. Liquid-liquid phase separation induces pathogenic tau conformations in vitro. Nat Commun. 2020;11:2809.
Clark A, Burleson M. SPOP and cancer: a systematic review. Am J Cancer Res. 2020;10:704–26.
Zhu G, Xie J, Kong W, Xie J, Li Y, Du L, et al. Phase separation of disease-associated SHP2 mutants underlies MAPK hyperactivation. Cell. 2020;183:490–502.
Zhang H, Chen Y, Jiang Y, Mao Z. DNA double-strand break repair and nucleic acid-related immunity. Acta Biochim Biophys Sin. 2022;54:828–35.
Toulany M. Targeting DNA double-strand break repair pathways to improve radiotherapy response. Genes. 2019;10:25.
Aricthota S, Rana PP, Haldar D. Histone acetylation dynamics in repair of DNA double-strand breaks. Front Genet. 2022;13:926577.
Derbyshire DJ, Basu BP, Serpell LC, Joo WS, Date T, Iwabuchi K, et al. Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor. EMBO J. 2002;21:3863–72.
Iwabuchi K, Bartel PL, Li B, Marraccino R, Fields S. Two cellular proteins that bind to wild-type but not mutant p53. Proc Natl Acad Sci USA. 1994;91:6098–102.
Panier S, Boulton SJ. Double-strand break repair: 53BP1 comes into focus. Nat Rev Mol Cell Biol. 2014;15:7–18.
Lei T, Du S, Peng Z, Chen L. Multifaceted regulation and functions of 53BP1 in NHEJ‑mediated DSB repair (Review). Int J Mol Med. 2022;50:90.
Mirman Z, de Lange T. 53BP1: a DSB escort. Gene Dev. 2020;34:7–23.
Bouwman P, Aly A, Escandell JM, Pieterse M, Bartkova J, van der Gulden H, et al. 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers. Nat Struct Mol Biol. 2010;17:688–95.
Swift ML, Beishline K, Flashner S, Azizkhan-Clifford J. DSB repair pathway choice is regulated by recruitment of 53BP1 through cell cycle-dependent regulation of Sp1. Cell Rep. 2021;34:108840.
Tehrani SS, Karimian A, Parsian H, Majidinia M, Yousefi B. Multiple functions of long non-coding RNAs in oxidative stress, DNA damage response and cancer progression. J Cell Biochem. 2018;119:223–36.
Feng L, Li N, Li Y, Wang J, Gao M, Wang W, et al. Cell cycle-dependent inhibition of 53BP1 signaling by BRCA1. Cell Discov. 2015;1:15019.
Lee JH, Goodarzi AA, Jeggo PA, Paull TT. 53BP1 promotes ATM activity through direct interactions with the MRN complex. EMBO J. 2010;29:574–85.
Zgheib O, Huyen Y, DiTullio RJ, Snyder A, Venere M, Stavridi ES, et al. ATM signaling and 53BP1. Radiother Oncol. 2005;76:119–22.
Her J, Ray C, Altshuler J, Zheng H, Bunting SF. 53BP1 mediates ATR-Chk1 signaling and protects replication forks under conditions of replication stress. Mol Cell Biol. 2018;38:e00472–17.
Cuella-Martin R, Oliveira C, Lockstone HE, Snellenberg S, Grolmusova N, Chapman JR. 53BP1 integrates DNA repair and p53-dependent cell fate decisions via distinct mechanisms. Mol Cell. 2016;64:51–64.
Meitinger F, Anzola JV, Kaulich M, Richardson A, Stender JD, Benner C, et al. 53BP1 and USP28 mediate p53 activation and G1 arrest after centrosome loss or extended mitotic duration. J Cell Biol. 2016;214:155–66.
Mirza-Aghazadeh-Attari M, Mohammadzadeh A, Yousefi B, Mihanfar A, Karimian A, Majidinia M. 53BP1: a key player of DNA damage response with critical functions in cancer. DNA Repair. 2019;73:110–9.
Ghodke I, Remisova M, Furst A, Kilic S, Reina-San-Martin B, Poetsch AR, et al. AHNAK controls 53BP1-mediated p53 response by restraining 53BP1 oligomerization and phase separation. Mol Cell. 2021;81:2596–610.
Zhang L, Geng X, Wang F, Tang J, Ichida Y, Sharma A, et al. 53BP1 regulates heterochromatin through liquid phase separation. Nat Commun. 2022;13:360.
D’Amours D, Desnoyers S, D’Silva I, Poirier GG. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem J. 1999;342:249–68.
Chambon P, Weill JD, Mandel P. Nicotinamide mononucleotide activation of new DNA-dependent polyadenylic acid synthesizing nuclear enzyme. Biochem Biophys Res Commun. 1963;11:39–43.
Curtin NJ, Szabo C. Poly(ADP-ribose) polymerase inhibition: past, present and future. Nat Rev Drug Discov. 2020;19:711–36.
De Vos M, Schreiber V, Dantzer F. The diverse roles and clinical relevance of PARPs in DNA damage repair: current state of the art. Biochem Pharmacol. 2012;84:137–46.
Wang Y, Luo W, Wang Y. PARP-1 and its associated nucleases in DNA damage response. DNA Repair. 2019;81:102651.
Donà F, Chiodi I, Belgiovine C, Raineri T, Ricotti R, Mondello C, et al. Poly(ADP-ribosylation) and neoplastic transformation: effect of PARP inhibitors. Curr Pharm Biotechnol. 2013;14:524–36.
Rodríguez MI, Majuelos-Melguizo J, Martí MJ, Ruiz DAM, López-Rivas A, Javier OF. Deciphering the insights of poly(ADP-ribosylation) in tumor progression. Med Res Rev. 2015;35:678–97.
Vida A, Márton J, Mikó E, Bai P. Metabolic roles of poly(ADP-ribose) polymerases. Semin Cell Dev Biol. 2017;63:135–43.
Bai P, Cantó C. The role of PARP-1 and PARP-2 enzymes in metabolic regulation and disease. Cell Metab. 2012;16:290–5.
Gupte R, Liu Z, Kraus WL. PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes. Genes Dev. 2017;31:101–26.
Kunze FA, Hottiger MO. Regulating immunity via ADP-ribosylation: therapeutic implications and beyond. Trends Immunol. 2019;40:159–73.
Jubin T, Kadam A, Gani AR, Singh M, Dwivedi M, Begum R. Poly ADP-ribose polymerase-1: beyond transcription and towards differentiation. Semin Cell Dev Biol. 2017;63:167–79.
Bürkle A, Virág L. Poly(ADP-ribose): PARadigms and PARadoxes. Mol Asp Med. 2013;34:1046–65.
Virág L, Robaszkiewicz A, Rodriguez-Vargas JM, Oliver FJ. Poly(ADP-ribose) signaling in cell death. Mol Asp Med. 2013;34:1153–67.
Haince JF, McDonald D, Rodrigue A, Déry U, Masson JY, Hendzel MJ, et al. PARP1-dependent kinetics of recruitment of MRE11 and NBS1 proteins to multiple DNA damage sites. J Biol Chem. 2008;283:1197–208.
Langelier MF, Riccio AA, Pascal JM. PARP-2 and PARP-3 are selectively activated by 5′ phosphorylated DNA breaks through an allosteric regulatory mechanism shared with PARP-1. Nucleic Acids Res. 2014;42:7762–75.
Singatulina AS, Hamon L, Sukhanova MV, Desforges B, Joshi V, Bouhss A, et al. PARP-1 activation directs FUS to DNA damage sites to form PARG-reversible compartments enriched in damaged DNA. Cell Rep. 2019;27:1809–21.
Krietsch J, Caron MC, Gagné JP, Ethier C, Vignard J, Vincent M, et al. PARP activation regulates the RNA-binding protein NONO in the DNA damage response to DNA double-strand breaks. Nucleic Acids Res. 2012;40:10287–301.
Cargill MJ, Morales A, Ravishankar S, Warren EH. RNA helicase, DDX3X, is actively recruited to sites of DNA damage in live cells. DNA Repair. 2021;103:103137.
Altmeyer M, Neelsen KJ, Teloni F, Pozdnyakova I, Pellegrino S, Grøfte M, et al. Liquid demixing of intrinsically disordered proteins is seeded by poly(ADP-ribose). Nat Commun. 2015;6:8088.
Leung A. Poly(ADP-ribose): a dynamic trigger for biomolecular condensate formation. Trends Cell Biol. 2020;30:370–83.
Duan Y, Du A, Gu J, Duan G, Wang C, Gui X, et al. PARylation regulates stress granule dynamics, phase separation, and neurotoxicity of disease-related RNA-binding proteins. Cell Res. 2019;29:233–47.
Crozat A, Aman P, Mandahl N, Ron D. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature. 1993;363:640–4.
Yang S, Warraich ST, Nicholson GA, Blair IP. Fused in sarcoma/translocated in liposarcoma: a multifunctional DNA/RNA binding protein. Int J Biochem Cell Biol. 2010;42:1408–11.
Sama RR, Ward CL, Bosco DA. Functions of FUS/TLS from DNA repair to stress response: implications for ALS. ASN Neuro. 2014;6:1759091414544472.
Hill SJ, Mordes DA, Cameron LA, Neuberg DS, Landini S, Eggan K, et al. Two familial ALS proteins function in prevention/repair of transcription-associated DNA damage. Proc Natl Acad Sci USA. 2016;113:E7701–9.
Mastrocola AS, Kim SH, Trinh AT, Rodenkirch LA, Tibbetts RS. The RNA-binding protein fused in sarcoma (FUS) functions downstream of poly(ADP-ribose) polymerase (PARP) in response to DNA damage. J Biol Chem. 2013;288:24731–41.
Rulten SL, Rotheray A, Green RL, Grundy GJ, Moore DA, Gómez-Herreros F, et al. PARP-1 dependent recruitment of the amyotrophic lateral sclerosis-associated protein FUS/TLS to sites of oxidative DNA damage. Nucleic Acids Res. 2014;42:307–14.
Wang WY, Pan L, Su SC, Quinn EJ, Sasaki M, Jimenez JC, et al. Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons. Nat Neurosci. 2013;16:1383–91.
Gardiner M, Toth R, Vandermoere F, Morrice NA, Rouse J. Identification and characterization of FUS/TLS as a new target of ATM. Biochem J. 2008;415:297–307.
Kanekura K, Kuroda M. How can we interpret the relationship between liquid-liquid phase separation and amyotrophic lateral sclerosis? Lab Invest. 2022;102:912–8.
Chen C, Ding X, Akram N, Xue S, Luo SZ. Fused in sarcoma: properties, self-assembly and correlation with neurodegenerative diseases. Molecules. 2019;24:1622.
Levone BR, Lenzken SC, Antonaci M, Maiser A, Rapp A, Conte F, et al. FUS-dependent liquid-liquid phase separation is important for DNA repair initiation. J Cell Biol. 2021;220:e202008030.
Reber S, Jutzi D, Lindsay H, Devoy A, Mechtersheimer J, Levone BR, et al. The phase separation-dependent FUS interactome reveals nuclear and cytoplasmic function of liquid-liquid phase separation. Nucleic Acids Res. 2021;49:7713–31.
Sukhanova MV, Singatulina AS, Pastré D, Lavrik OI. Fused in sarcoma (FUS) in DNA repair: tango with poly(ADP-ribose) polymerase 1 and compartmentalisation of damaged DNA. Int J Mol Sci. 2020;21:7020.
Knott GJ, Bond CS, Fox AH. The DBHS proteins SFPQ, NONO and PSPC1: a multipurpose molecular scaffold. Nucleic Acids Res. 2016;44:3989–4004.
Mircsof D, Langouët M, Rio M, Moutton S, Siquier-Pernet K, Bole-Feysot C, et al. Mutations in NONO lead to syndromic intellectual disability and inhibitory synaptic defects. Nat Neurosci. 2015;18:1731–6.
Salton M, Lerenthal Y, Wang SY, Chen DJ, Shiloh Y. Involvement of Matrin 3 and SFPQ/NONO in the DNA damage response. Cell Cycle. 2010;9:1568–76.
Yang YS, Yang MC, Tucker PW, Capra JD. NonO enhances the association of many DNA-binding proteins to their targets. Nucleic Acids Res. 1997;25:2284–92.
Benegiamo G, Mure LS, Erikson G, Le HD, Moriggi E, Brown SA, et al. The RNA-binding protein NONO coordinates hepatic adaptation to feeding. Cell Metab. 2018;27:404–18.
Jiang L, Shao C, Wu QJ, Chen G, Zhou J, Yang B, et al. NEAT1 scaffolds RNA-binding proteins and the microprocessor to globally enhance pri-miRNA processing. Nat Struct Mol Biol. 2017;24:816–24.
Alfano L, Costa C, Caporaso A, Altieri A, Indovina P, Macaluso M, et al. NONO regulates the intra-S-phase checkpoint in response to UV radiation. Oncogene. 2016;35:567–76.
Bladen CL, Udayakumar D, Takeda Y, Dynan WS. Identification of the polypyrimidine tract binding protein-associated splicing factor.p54(nrb) complex as a candidate DNA double-strand break rejoining factor. J Biol Chem. 2005;280:5205–10.
Jaafar L, Li Z, Li S, Dynan WS. SFPQ•NONO and XLF function separately and together to promote DNA double-strand break repair via canonical nonhomologous end joining. Nucleic Acids Res. 2017;45:1848–59.
Fan XJ, Wang YL, Zhao WW, Bai SM, Ma Y, Yin XK, et al. NONO phase separation enhances DNA damage repair by accelerating nuclear EGFR-induced DNA-PK activation. Am J Cancer Res. 2021;11:2838–52.
Sharma D, Putnam AA, Jankowsky E. Biochemical differences and similarities between the DEAD-box helicase orthologs DDX3X and Ded1p. J Mol Biol. 2017;429:3730–42.
Linder P, Jankowsky E. From unwinding to clamping - the DEAD box RNA helicase family. Nat Rev Mol Cell Biol. 2011;12:505–16.
Wang T, Birsoy K, Hughes NW, Krupczak KM, Post Y, Wei JJ, et al. Identification and characterization of essential genes in the human genome. Science. 2015;350:1096–101.
Chen CY, Chan CH, Chen CM, Tsai YS, Tsai TY, Wu LY, et al. Targeted inactivation of murine Ddx3x: essential roles of Ddx3x in placentation and embryogenesis. Hum Mol Genet. 2016;25:2905–22.
Bol GM, Vesuna F, Xie M, Zeng J, Aziz K, Gandhi N, et al. Targeting DDX3 with a small molecule inhibitor for lung cancer therapy. EMBO Mol Med. 2015;7:648–69.
Chan CH, Chen CM, Lee YW, You LR. DNA damage, liver injury, and tumorigenesis: consequences of DDX3X loss. Mol Cancer Res. 2019;17:555–66.
Kai M. Roles of RNA-binding proteins in DNA damage response. Int J Mol Sci. 2016;17:310.
Yates LA. Regulation of DNA break repair by RNA. Prog Biophys Mol Biol. 2021;163:23–33.
Gai X, Xin D, Wu D, Wang X, Chen L, Wang Y, et al. Pre-ribosomal RNA reorganizes DNA damage repair factors in nucleus during meiotic prophase and DNA damage response. Cell Res. 2022;32:254–68.
Staples CJ, Barone G, Myers KN, Ganesh A, Gibbs-Seymour I, Patil AA, et al. MRNIP/C5orf45 interacts with the MRN complex and contributes to the DNA damage response. Cell Rep. 2016;16:2565–75.
Bennett LG, Wilkie AM, Antonopoulou E, Ceppi I, Sanchez A, Vernon EG, et al. MRNIP is a replication fork protection factor. Sci Adv. 2020;6:a5974.
Wang YL, Zhao WW, Bai SM, Feng LL, Bie SY, Gong L, et al. MRNIP condensates promote DNA double-strand break sensing and end resection. Nat Commun. 2022;13:2638.
Kazi S, Castañeda JM, Savolainen A, Xu Y, Liu N, Qiao H, et al. MRNIP interacts with sex body chromatin to support meiotic progression, spermatogenesis, and male fertility in mice. FASEB J. 2022;36:e22479.
Symington LS, Rothstein R, Lisby M. Mechanisms and regulation of mitotic recombination in Saccharomyces cerevisiae. Genetics. 2014;198:795–835.
Bordelet H, Dubrana K. Keep moving and stay in a good shape to find your homologous recombination partner. Curr Genet. 2019;65:29–39.
Oshidari R, Huang R, Medghalchi M, Tse E, Ashgriz N, Lee HO, et al. DNA repair by Rad52 liquid droplets. Nat Commun. 2020;11:695.
Miné-Hattab J, Heltberg M, Villemeur M, Guedj C, Mora T, Walczak AM, et al. Single molecule microscopy reveals key physical features of repair foci in living cells. Elife. 2021;10:e60577.
Thorstensen T, Fischer A, Sandvik SV, Johnsen SS, Grini PE, Reuter G, et al. The Arabidopsis SUVR4 protein is a nucleolar histone methyltransferase with preference for monomethylated H3K9. Nucleic Acids Res. 2006;34:5461–70.
Han YF, Dou K, Ma ZY, Zhang SW, Huang HW, Li L, et al. SUVR2 is involved in transcriptional gene silencing by associating with SNF2-related chromatin-remodeling proteins in Arabidopsis. Cell Res. 2014;24:1445–65.
Liu Q, Liu P, Ji T, Zheng L, Shen C, Ran S, et al. The histone methyltransferase SUVR2 promotes DSB repair via chromatin remodeling and liquid-liquid phase separation. Mol Plant. 2022;15:1157–75.
Chiolo I, Minoda A, Colmenares SU, Polyzos A, Costes SV, Karpen GH. Double-strand breaks in heterochromatin move outside of a dynamic HP1a domain to complete recombinational repair. Cell. 2011;144:732–44.
Li W, Hu J, Shi B, Palomba F, Digman MA, Gratton E, et al. Biophysical properties of AKAP95 protein condensates regulate splicing and tumorigenesis. Nat Cell Biol. 2020;22:960–72.
Tong X, Tang R, Xu J, Wang W, Zhao Y, Yu X, et al. Liquid-liquid phase separation in tumor biology. Signal Transduct Target Ther. 2022;7:221.
Ming Y, Chen X, Xu Y, Wu Y, Wang C, Zhang T, et al. Targeting liquid-liquid phase separation in pancreatic cancer. Transl Cancer Res. 2019;8:96–103.
Iconaru LI, Das S, Nourse A, Shelat AA, Zuo J, Kriwacki RW. Small molecule sequestration of the intrinsically disordered protein, p27(Kip1), within soluble oligomers. J Mol Biol. 2021;433:167120.
Sadar MD. Discovery of drugs that directly target the intrinsically disordered region of the androgen receptor. Expert Opin Drug Discov. 2020;15:551–60.
Myung JK, Banuelos CA, Fernandez JG, Mawji NR, Wang J, Tien AH, et al. An androgen receptor N-terminal domain antagonist for treating prostate cancer. J Clin Invest. 2013;123:2948–60.
Imamura Y, Tien AH, Pan J, Leung JK, Banuelos CA, Jian K, et al. An imaging agent to detect androgen receptor and its active splice variants in prostate cancer. JCI Insight. 2016;1:e87850.
Spegg V, Altmeyer M. Biomolecular condensates at sites of DNA damage: more than just a phase. DNA Repair. 2021;106:103179.
Chu X, Sun T, Li Q, Xu Y, Zhang Z, Lai L, et al. Prediction of liquid-liquid phase separating proteins using machine learning. BMC Bioinformatics. 2022;23:72.
Bracha D, Walls MT, Wei MT, Zhu L, Kurian M, Avalos JL, et al. Mapping local and global liquid phase behavior in living cells using photo-oligomerizable seeds. Cell. 2018;175:1467–80.
Funding
This work was supported by the National Key R&D Program of China (No. 2022YFA1105300, No. 2022YFC2503700); the National Science Fund for Distinguished Young Scholars (No. 82225040); the National Science Fund for Excellent Young Scholars (No. 82122057); the Natural Science Foundation of China (No. 82373513, No. 82103770, No. 82171163); Guangdong Natural Science Funds for Distinguished Young Scholars (No. 2021B1515020022); Guangdong Science and Technology Project (No. 2022A1515012363, 2023B1515020090); Beijing Bethune Charitable Foundation (No. flzh202102); and Fundamental Research Funds for the Central Universities (No. 22qntd3602).
Author information
Authors and Affiliations
Contributions
YLW, WWZ, and JS drafted the original manuscript. YLW and WWZ designed and created the figures. YLW, XBW, JZ, and XJF structured and revised the manuscript. All authors have read and agreed to the final version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Edited by Dr Francesca Bernassola
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wang, YL., Zhao, WW., Shi, J. et al. Liquid-liquid phase separation in DNA double-strand breaks repair. Cell Death Dis 14, 746 (2023). https://doi.org/10.1038/s41419-023-06267-0
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41419-023-06267-0